Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100051499Phase 4Recruiting
Phase 4, randomised trial of crisaborole in dermatitis (2 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoint: Eczema Area and Severity Index (EASI) score. Started Sep 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100051499.